Jane Street
BEAM icon

Jane Street’s Beam Therapeutics BEAM Stock Holding History

Jane Street’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$886K Buy
37,200
+8,900
+31% +$247K ﹤0.01% 6780
2025
Q4 		$784K Sell
28,300
-28,500
-50% -$727K ﹤0.01% 6665
2025
Q3 		$1.38M Sell
56,800
-403,900
-88% -$8.04M ﹤0.01% 5645
2025
Q2 		$7.84M Buy
460,700
+425,000
+1,190% +$7.4M ﹤0.01% 2446
2025
Q1 		$697K Buy
35,700
+27,300
+325% +$715K ﹤0.01% 6247
2024
Q4 		$208K Buy
+8,400
New +$214K ﹤0.01% 8345
2024
Q3 		– Sell
-18,500
Closed -$433K – 9574
2024
Q2 		$433K Sell
18,500
-17,500
-49% -$430K ﹤0.01% 7249
2024
Q1 		$1.19M Buy
36,000
+26,400
+275% +$822K ﹤0.01% 5088
2023
Q4 		$261K Sell
9,600
-79,400
-89% -$1.97M ﹤0.01% 7830
2023
Q3 		$2.14M Buy
89,000
+61,400
+222% +$1.65M ﹤0.01% 3946
2023
Q2 		$881K Sell
27,600
-38,900
-58% -$1.26M ﹤0.01% 5411
2023
Q1 		$2.04M Buy
66,500
+42,400
+176% +$1.67M ﹤0.01% 3789
2022
Q4 		$943K Sell
24,100
-51,600
-68% -$2.31M ﹤0.01% 5075
2022
Q3 		$3.61M Sell
75,700
-83,200
-52% -$4.75M ﹤0.01% 3163
2022
Q2 		$6.15M Buy
158,900
+15,500
+11% +$616K ﹤0.01% 2361
2022
Q1 		$8.22M Buy
143,400
+133,800
+1,394% +$8.78M ﹤0.01% 2252
2021
Q4 		$765K Sell
9,600
-22,700
-70% -$1.94M ﹤0.01% 6445
2021
Q3 		$2.81M Sell
32,300
-2,000
-6% -$201K ﹤0.01% 3788
2021
Q2 		$4.42M Buy
34,300
+23,600
+221% +$1.88M ﹤0.01% 2863
2021
Q1 		$856K Buy
10,700
+200
+2% +$19K ﹤0.01% 5752
2020
Q4 		$857K Buy
+10,500
New +$516K ﹤0.01% 4916

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Jane Street's BEAM Position: Q3 2025 in Review

Jane Street sold out of Beam Therapeutics (BEAM) in Q3 2025, closing a stake of 310,010 shares — an estimated $6.17M sold.

Jane Street first reported a position in BEAM in Q4 2020 and held it in 18 quarters. The position peaked at $10.5M in Q2 2024. 218 funds tracked by Wall St. Rank hold BEAM as of Q3 2025.

  • Jane Street reported no remaining Beam Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Jane Street sold 310,010 Beam Therapeutics shares in Q3 2025, an estimated $6.17M.
  • Jane Street first reported a position in Beam Therapeutics in Q4 2020 and held it in 18 quarters.
  • Jane Street's Beam Therapeutics position peaked at $10.5M in Q2 2024.
  • 218 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2025.

Based on Jane Street's 13F filing for Q3 2025, filed 14 Nov 2025.